Oxford University enters into licensing arrangement with Serum Institute of India to develop Rift Valley fever vaccine candidate
On Jan. 12, 2026, With support from the epidemic preparedness organisation Coalition for Epidemic Preparedness Innovations (CEPI), Serum…